Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating income	$ 1,161	$ 2,288	$ 2,568	$ 4,482
Operating expenses
Research and development expenses	(25,374)	(17,616)	(46,777)	(33,653)
Sales and marketing expenses	(986)	(516)	(1,744)	(950)
General and administrative expenses	(8,643)	(9,231)	(16,447)	(16,120)
Total Operating expenses	(35,003)	(27,364)	(64,968)	(50,723)
Loss from operations	(33,842)	(25,076)	(62,400)	(46,242)
Financial income(expenses)	726	846	1,986	1,450
Loss before taxes	(33,116)	(24,230)	(60,413)	(44,791)
Income tax (expense)	0	(13)	(48)	(13)
Net loss	(33,116)	(24,243)	(60,461)	(44,804)
Foreign currency translation differences, net of taxes	(1,001)	(221)	(4,027)	3,445
Actuarial gains (losses) on employee benefits, net of taxes	67	(10)	8	(92)
Total comprehensive loss	$ (34,051)	$ (24,475)	$ (64,480)	$ (41,452)
Basic Net loss per share attributable to shareholders	$ (0.34)	$ (0.26)	$ (0.63)	$ (0.48)
Weighted average shares outstanding used in computing per share amounts:	96,170,285	94,324,889	96,179,388	94,150,141
Diluted Net loss per share attributable to shareholders	$ (0.34)	$ (0.26)	$ (0.63)	$ (0.48)
Weighted average shares outstanding used in computing per share amounts:	96,170,285	94,324,889	96,179,388	94,150,141